Sael M. Alatawi

Tabuk, 71491, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Phenylketonuria in Saudi Arabia: An Overview of Diagnosis, Genetics, and Therapeutic Strategies.

Phenylketonuria in Saudi Arabia: An Overview of Diagnosis, Genetics, and Therapeutic Strategies.

Journal: Biology
Published: June 06, 2026

Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.

Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 16, 2025

Clinical exome sequencing identifies novel gene variants associated with ischemic stroke in the Saudi Tabuk population.

Clinical exome sequencing identifies novel gene variants associated with ischemic stroke in the Saudi Tabuk population.

Journal: Frontiers in human neuroscience
Published: June 12, 2025

Correction: Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.

Correction: Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.

Journal: Biochemical genetics
Published: January 20, 2025

Exploring the genetic frontier: Unraveling ANRIL, PAI-1, and HNF1α in stroke progression.

Exploring the genetic frontier: Unraveling ANRIL, PAI-1, and HNF1α in stroke progression.

Journal: PloS one
Published: December 28, 2024

Genetic Variations in BCL3, MDM4, KLF14, and miR-146a and Their Associations with the Predisposition and Progression of Myeloproliferative Disorder and Chronic Myeloid Leukemia Patients.

Genetic Variations in BCL3, MDM4, KLF14, and miR-146a and Their Associations with the Predisposition and Progression of Myeloproliferative Disorder and Chronic Myeloid Leukemia Patients.

Journal: Molecular syndromology
Published: November 23, 2024

Identification of UBA7 expression downregulation in myelodysplastic neoplasm with SF3B1 mutations.

Identification of UBA7 expression downregulation in myelodysplastic neoplasm with SF3B1 mutations.

Journal: Scientific reports
Published: October 19, 2024

Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.

Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.

Journal: Discovery medicine
Published: July 26, 2024

New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS).

New insights into PSAT1 as a therapeutic target for myelodysplastic syndrome (MDS).

Journal: PloS one
Published: May 23, 2024

Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.

Identification of Novel Genomic Variants in COVID-19 Patients Using Whole-Exome Sequencing: Exploring the Plausible Targets of Functional Genomics.

Journal: Biochemical genetics
Published: February 12, 2024

Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma.

Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma.

Journal: Cancers
Published: November 28, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026